Description
contains 10% refined soybean oil, 1.2% purified egg lecithin, and 2.25% glycerol. This formulation serves as a concentrated source of calories and essential fatty acids, primarily linoleic acid, which are vital for patients requiring parenteral nutrition. Fatisol is indicated for conditions such as preoperative and postoperative nutritional disturbances, gastrointestinal disorders with impaired absorption, burns, prolonged unconsciousness, impaired renal function, cachexia, and essential fatty acid deficiency. It is administered intravenously, either via a peripheral or central vein, and is isotonic, making it suitable for long-term use when enteral feeding is inappropriate or impossible. The recommended dosage varies based on age and clinical condition, and it should be used under medical supervision. Fatisol is contraindicated in patients with severely disordered fat metabolism, such as severe liver damage or acute shock,
.jpg)
Change Language